Reaction

Inappropriate Schedule Of Product Discontinuation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 504 reports · 3 co-occurring drugs

As of the last recalculation, Inappropriate Schedule Of Product Discontinuation appears in 504 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (PRR 284.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Buprenorphine Hydrochloride, Naloxone Hydrochloride	125	284.2	285.7
Inclisiran	4	20.8	20.8
Buprenorphine	32	15.2	15.2

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.